UnitedHealth to Acquire Amedisys for $101/Share
By Dean Seal
UnitedHealth Group has agreed to acquire Amedisys for $101 a share.
The healthcare-services provider said in a securities filing on Monday it has agreed to a merger with UnitedHealth in which each Amedisys share will be converted into the right to $101 in cash.
Amedisys will become a wholly owned subsidiary of UnitedHealth.
The Baton Rouge, La.-based company said earlier this month that it had received an unsolicited proposal from a unit of UnitedHealth for a takeover at $100 a share.
The new bid disrupted Amedisys' previously announced plans to combine with Option Care in an all-stock deal.
Amedisys shares ticked up by less than 1% to $91.74 in premarket trading.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
June 26, 2023 09:09 ET (13:09 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
After Earnings, Is Coinbase Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?
-
The Best REITs to Buy
-
3 Hot Stocks to Buy That Still Look Undervalued
-
After Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
Today’s Market Volatility Could Provide Tomorrow’s Opportunities
-
40 of the Best Investment Picks
-
Tech Stock Dividends Are Changing the Face of Dividend Growth Investing
-
Roblox Earnings: Weakening Engagement Has Weighed On Growth
-
The Best Gaming Stocks to Buy